GEP20094628B - (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders - Google Patents

(s,s)-reboxetine for treating fibromyalgia and other somatoform disorders

Info

Publication number
GEP20094628B
GEP20094628B GEAP200010717A GEAP2000010717A GEP20094628B GE P20094628 B GEP20094628 B GE P20094628B GE AP200010717 A GEAP200010717 A GE AP200010717A GE AP2000010717 A GEAP2000010717 A GE AP2000010717A GE P20094628 B GEP20094628 B GE P20094628B
Authority
GE
Georgia
Prior art keywords
reboxetine
somatoform disorders
treating fibromyalgia
fibromyalgia
somatoform
Prior art date
Application number
GEAP200010717A
Inventor
Erik H F Wong
Duncan P Taylor
Robert Macarthur
Robert Clyde Marshall
Pasquale Cetera
Lars Birgerson
Saeeduddin Ahmed
Original Assignee
Pharmacia And Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia And Upjohn Company Llc filed Critical Pharmacia And Upjohn Company Llc
Publication of GEP20094628B publication Critical patent/GEP20094628B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, said compound being substantially free of (R,R)-reboxetine, in the manufacture of a medicament for the treatment or prevention of fibromyalgia or another somatoform disorder.
GEAP200010717A 1999-07-01 2000-06-22 (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders GEP20094628B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14196899A 1999-07-01 1999-07-01
US14413199A 1999-07-16 1999-07-16
US15825699A 1999-10-06 1999-10-06
US17038199A 1999-12-13 1999-12-13

Publications (1)

Publication Number Publication Date
GEP20094628B true GEP20094628B (en) 2009-03-10

Family

ID=79330746

Family Applications (2)

Application Number Title Priority Date Filing Date
GEAP200010659A GEP20094626B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating peripheral neuropathy
GEAP200010717A GEP20094628B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GEAP200010659A GEP20094626B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating peripheral neuropathy

Country Status (1)

Country Link
GE (2) GEP20094626B (en)

Also Published As

Publication number Publication date
GEP20094626B (en) 2009-03-10

Similar Documents

Publication Publication Date Title
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
WO1999036064A3 (en) Methods of treating tardive dyskinesia and other movement disorders
UA41355C2 (en) Agent for treating neuro-aids
MY119375A (en) Treatment of tinnitus using neuroprotective agents
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
WO1998026770A3 (en) The topical use of kappa opioid agonists to treat ocular pain
WO2000051582A3 (en) Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
HK1024631A1 (en) Use of (+) mefloquine for the treatment of malaria
GB0020504D0 (en) Therapeutic method
GB9521608D0 (en) Pharmaceutical composition
MXPA02011921A (en) Naaladase inhibitors for treating retinal disorders and glaucoma.
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
HK1073779A1 (en) The use of darifenacin and the salt thereof
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
HK1047695A1 (en) Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
GEP20094628B (en) (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
EP1632234A3 (en) (S,S)-reboxetine for treating chronic fatigue syndrome
NZ501365A (en) Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma
AU5434899A (en) Cancer treatment
MX9604692A (en) Quinoxaline derivatives for treating tinnitus.
AU2177401A (en) Combination of riluzole and gabapentin and use thereof as medicine
YU17002A (en) Dextrazohane use in psoriasis healing